Identification of PARP12 Inhibitors By Virtual Screening and Molecular Dynamics Simulations
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Almeleebia, Tahani M. | - |
dc.contributor.author | Ahamad, Shahzaib | - |
dc.contributor.author | Ahmad, Irfan | - |
dc.contributor.author | Alshehri, Ahmad | - |
dc.contributor.author | Alkhathami, Ali G. | - |
dc.contributor.author | Alshahrani, Mohammad Y. | - |
dc.contributor.author | Asiri, Mohammed A. | - |
dc.contributor.author | Saeed, Amir | - |
dc.contributor.author | Siddiqui, Jamshaid Ahmad | - |
dc.contributor.author | Yadav, Dharmendra K. | - |
dc.contributor.author | Saeed, Mohd | - |
dc.date.accessioned | 2022-09-27T06:40:25Z | - |
dc.date.available | 2022-09-27T06:40:25Z | - |
dc.date.created | 2022-09-22 | - |
dc.date.issued | 2022-08 | - |
dc.identifier.issn | 1663-9812 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/85567 | - |
dc.description.abstract | Poly [adenosine diphosphate (ADP)-ribose] polymerases (PARPs) are members of a family of 17 enzymes that performs several fundamental cellular processes. Aberrant activity (mutation) in PARP12 has been linked to various diseases including inflammation, cardiovascular disease, and cancer. Herein, a large library of compounds (ZINC-FDA database) has been screened virtually to identify potential PARP12 inhibitor(s). The best compounds were selected on the basis of binding affinity scores and poses. Molecular dynamics (MD) simulation and binding free energy calculation (MMGBSA) were carried out to delineate the stability and dynamics of the resulting complexes. To this end, root means deviations, relative fluctuation, atomic gyration, compactness, covariance, residue-residue contact map, and free energy landscapes were studied. These studies have revealed that compounds ZINC03830332, ZINC03830554, and ZINC03831186 are promising agents against mutated PARP12. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | FRONTIERS MEDIA SA | - |
dc.relation.isPartOf | FRONTIERS IN PHARMACOLOGY | - |
dc.title | Identification of PARP12 Inhibitors By Virtual Screening and Molecular Dynamics Simulations | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000843802600001 | - |
dc.identifier.doi | 10.3389/fphar.2022.847499 | - |
dc.identifier.bibliographicCitation | FRONTIERS IN PHARMACOLOGY, v.13 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.scopusid | 2-s2.0-85136583928 | - |
dc.citation.title | FRONTIERS IN PHARMACOLOGY | - |
dc.citation.volume | 13 | - |
dc.contributor.affiliatedAuthor | Yadav, Dharmendra K. | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | PARP12 | - |
dc.subject.keywordAuthor | ZINC-FDA | - |
dc.subject.keywordAuthor | virtual screening | - |
dc.subject.keywordAuthor | MMGBSA | - |
dc.subject.keywordAuthor | MD simulations | - |
dc.subject.keywordPlus | HIGH-THROUGHPUT | - |
dc.subject.keywordPlus | GROMACS | - |
dc.subject.keywordPlus | DISCOVERY | - |
dc.subject.keywordPlus | DOCKING | - |
dc.subject.keywordPlus | ROLES | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.